Waste and harm in the treatment of mild hypertension

JAMA Internal Medicine

Volumn 173, Issue 11, 2013, Pages 956-957

  Heath, Iona ^a  

^a ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BORDERLINE HYPERTENSION; CARDIOVASCULAR RISK; DRUG INDUSTRY; LIFESTYLE MODIFICATION; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY;

ANTIHYPERTENSIVE AGENTS; DRUG UTILIZATION; HUMANS; HYPERTENSION; SEVERITY OF ILLNESS INDEX;

EID: 84878811646     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.970     Document Type: Short Survey

References (9)

1. Diao D, Wright JM, Cundiff DK, Gueyffier F. Pharmacotherapy formild hypertension. Cochrane Database Syst Rev. 2012;8(3):CD006742.
2. Hart JT. Cochrane review finds no proved benefit in drug treatment for patients with mild hypertension. BMJ. 2012;345:e5511.
3. Schwartz LM, Woloshin S. Changing disease definitions: implications for disease prevalence: analysis of the Third National Health and Nutrition Examination Survey, 1988-1994. Eff Clin Pract. 1999;2(2):76-85.
4. Woodman R. Open letter disputes WHO hypertension guidelines. BMJ. 1999;318(7188):893B.
5. De Backer G, Ambrosioni E, Borch-Johnsen K, et al Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24(17):1601-1610.
6. Getz L, Kirkengen AL, Hetlevik I, Romundstad S, Sigurdsson JA. Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice: a descriptive epidemiological study. Scand J Prim Health Care. 2004;22(4):202-208. (Pubitemid 39601980)
7. National Heart, Lung, and Blood Institute. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: complete report. 2004. http://www.nhlbi.nih.gov/guidelines/ hypertension/jnc7full.htm. Accessed January 8, 2013.
8. Ogedegbe G. Labeling and hypertension: it is time to intervene on its negative consequences. Hypertension. 2010;56(3):344-345.
9. Ghosh A. The Calcutta Chromosome. New Delhi, India: Ravi Dayal Publisher; 1996.